Outlook Therapeutics Inc.

OTLK | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.70

+$0.01 (+2.00%)

Sep 22, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $128.34M

Enterprise Value $117.09M

Beta 0.75

Average Volume 20.78M

Shares Outstanding (Diluted) 136.74M

Shares Change YoY 270.01%

Institutional Ownership 42.10%

Exchange NASDAQ

ISIN US69012T3059

Price Performance

Price Change 1M 11.3%

Price Change 3M -59.4%

Price Change 6M 231.7%

Price Change YTD 4.5%

Price Change 1Y -28.7%

Price Change 3Y -83.5%

Price Change 5Y -98.5%

1M CAGR (ann.) -32.7%

1Y CAGR (ann.) -30.7%

5Y CAGR (ann.) -57.6%

All-Time CAGR -48.9%

Valuation

PE Ratio -0.57

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.01

PS Ratio -110.33

Forward PS 2.90

PB Ratio 4.90

P/FCF Ratio -2.73

P/Adj. FCF Ratio -2.46

P/OCF Ratio -0.31

EV/Sales -100.67

EV/EBIT -1.88

EV/EBITDA -1.88

EV/FCF -2.49

Earnings Yield -176.8%

FCF Yield -36.7%

Adj. FCF Yield -40.7%

Financial Health

Net Cash $11.24M

Total Debt $0

Cash & Short-Term Investments $11.24M

Total Assets $26.19M

Current Ratio 0.81

Quick Ratio 0.63

Debt / Equity Ratio -1.77

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -210.62

Altman Z-Score -8.16

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 195.6%

Operating Profit Margin 4783.1%

EBITDA Margin 5354.4%

Net Profit Margin 5254.8%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue -297.4%

SBC Impact (per share) -10.9%

Returns

Return on Assets -233.4%

Return on Equity 222.0%

Return on Invested Capital -343.7%

Return on Capital Employed 2230.6%

Return on Tangible Assets -233.4%

Historical Growth (CAGR)

Revenue CAGR 3Y -340.6%

Revenue CAGR 5Y -63.5%

Revenue CAGR 10Y -30.5%

EPS CAGR 3Y 110.1%

EPS CAGR 5Y 30.0%

EPS CAGR 10Y 42.7%

FCF CAGR 3Y 9.9%

FCF CAGR 5Y -0.1%

FCF CAGR 10Y -7.7%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 14

EPS Growth Next 3Y 52.4%

Revenue Growth Next 3Y 7568.3%

Earnings Date Dec 17, 2026

EPS Estimate (next Q) -$0.06

EPS Growth Est (next Q) -72.7%

Revenue Est (next Q) $2.7M

Revenue Growth Est (next Q) -2804.8%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $2.80

Price Target Upside 305.8%

Cash Flow

Operating Cash Flow $-47.05M

Free Cash Flow $-47.05M

Adj. Free Cash Flow $-52.19M

FCF Per Share -$2.24

OCF Per Share -$2.24

OCF/S Ratio 4911.7%

Income Statement

Revenue $-1.16M

Gross Profit $-2.28M

Operating Income $-55.64M

EBITDA $-62.28M

Net Income $-61.12M

EPS (Diluted) -$1.22

Revenue / Employee $-68.42K

Profit / Employee $-3.6M

Employees 17